Loading organizations...
Medigate by Claroty is a technology company.
Medigate by Claroty offers a specialized cybersecurity platform designed to protect connected medical devices and the Internet of Medical Things (IoMT) across healthcare environments. The system provides deep visibility, threat detection, and vulnerability management for cyber-physical systems within clinical networks. It continuously identifies devices, assesses risks, and enforces security policies, safeguarding patient data and critical operations.
Jonathan Langer, Itay Kirshenbaum, and Pini Pinhasov founded Medigate in 2017. They recognized the significant, unaddressed security risks from proliferating networked medical devices. This insight led them to develop a pioneering platform specifically for IoMT security, tailored to the unique demands of healthcare environments.
Healthcare providers deploy Medigate to secure their digital infrastructures, maintaining clinical operations and patient well-being. The company envisions enabling healthcare organizations to confidently adopt connected technologies. It secures their entire cyber-physical ecosystem, ensuring high-quality, protected patient care.
Medigate by Claroty has raised $332.0M across 6 funding rounds.
Medigate by Claroty has raised $332.0M in total across 6 funding rounds.
Medigate by Claroty is a modular, SaaS-based cybersecurity platform purpose-built for healthcare organizations, providing comprehensive visibility, risk management, threat detection, and protection for cyber-physical systems (CPS) including Internet of Medical Things (IoMT), IoT, operational technology (OT), and building management systems (BMS).[2][3][4][5] It serves hospitals, clinics, laboratories, and health delivery organizations (HDOs) worldwide, solving critical challenges like device blind spots in traditional IT security, cyber threats to medical devices, regulatory compliance, and downtime minimization amid IT/OT convergence.[1][2][5][7] The platform has demonstrated strong growth, securing over 10 million IoT devices and more than 7 million IoMT devices across thousands of hospitals, earning Best in KLAS for Healthcare IoT Security for four consecutive years with a 95.4/100 score.[4][7]
Medigate emerged as a specialized healthcare cybersecurity solution, founded around 2017 and initially operating independently before its acquisition by Claroty in January 2022.[1][2] Claroty itself was established in 2015 in New York (later Brooklyn), focusing on CPS protection across industrial, healthcare, commercial, and public sectors.[1] The acquisition combined Medigate's expertise in medical device security with Claroty's industrial OT leadership, backed by investors like SoftBank Vision Fund 2, Bessemer Venture Partners, and Schneider Electric, creating a unified platform for extended IoT (XIoT) in healthcare.[2][6] Early traction came from deploying in thousands of hospitals globally, interpreting over 500 device protocols via passive and light-active techniques, and addressing rising cyber risks in connected care environments.[4][5]
Medigate by Claroty rides the surge in digital transformation, IT/OT convergence, and XIoT proliferation in healthcare, where connected medical devices and BMS create exploitable blind spots amid escalating ransomware and nation-state threats.[1][6][7] Timing is ideal as HDOs face exponential risks from sensitive patient data and legacy devices, driving demand for purpose-built CPS security over generic IT tools.[2][7] Market forces like regulatory pressures (e.g., compliance standards) and the need for operational resilience favor its scalable, SaaS model, which has deployed globally and earned top customer validation.[3][4][7] It influences the ecosystem by enabling safe connected care, bridging industrial OT with healthcare IoMT, and setting benchmarks for visibility and zero-trust in critical infrastructure.[1][5][6]
Medigate by Claroty is poised for expanded dominance in healthcare XIoT security, leveraging Claroty's resources to innovate in AI-driven threat hunting, deeper protocol support, and global scaling beyond its current 2,000+ HDO footprint.[6][7] Trends like AI-enhanced anomaly detection, zero-day attack defenses, and hybrid IT/OT environments will propel growth, especially as cyber risks intensify with 5G-enabled devices and regulatory evolution.[3][5] Its influence may evolve into a full-spectrum XIoT leader, powering resilient ecosystems where healthcare safely integrates millions more devices—solidifying its role from niche protector to indispensable guardian of connected care.[4][6]
Medigate by Claroty has raised $332.0M in total across 6 funding rounds.
Medigate by Claroty's investors include Robert Tuchscherer, Dan Williams, Lewis Leavitt, Rockwell Automation, SE Ventures, Samir Paul, Standard Investments, Toshiba Digital Solutions, Partech Ventures, Blumberg Capital, rocketship.vc, Jacques Benkoski.
Medigate by Claroty has raised $332.0M across 6 funding rounds. Most recently, it raised $150.0M Claroty - Series F in January 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 22, 2026 | $150.0M Claroty - Series F | Robert Tuchscherer | |
| Mar 6, 2024 | $100.0M Claroty - Other Equity | Dan Williams | Lewis Leavitt, Rockwell Automation, SE Ventures, Samir Paul, Standard Investments, Toshiba Digital Solutions |
| Sep 1, 2020 | $30.0M Series B | Partech Ventures | Blumberg Capital, rocketship.vc, Jacques Benkoski, U.S. Venture Partners, Aaron Rosenson, Maor Investments, Yoav Andrew Leitersdorf |
| Jan 1, 2019 | $15.0M Series A | U.S. Venture Partners | Blumberg Capital, rocketship.vc, Aaron Rosenson, Yoav Andrew Leitersdorf |
| Nov 1, 2017 | $5.0M Seed | Yoav Andrew Leitersdorf | Blumberg Capital, rocketship.vc |
| Sep 13, 2016 | $32.0M Claroty - Other Equity | David Cowan, ICV, Eric Schmidt, Marker, Zvika Naggan |